LILLY ELI & CO LLY

expiry = 2019-03-08.... Item 4(a) of the Schedule TO, which incorporates by reference the information contained in the Exchange Offer, is hereby amended and supplemented by adding the following thereto: The Exchange Offer expired at 12:00 midnight, New York City time, at the end of the day on March 8, 2019. Lilly accepted for exchange 65,000,775 shares of Lilly common stock in exchange for 293,290,000 shares of Elanco common stock owned by Lilly. Each share of Lilly common stock accepted for exchange by Lilly was exchanged for 4.5121 shares...

must_tender_all = True...tion of the shares of Lilly common stock that were validly tendered and not validly withdrawn, on a pro rata basis in proportion to the number of shares tendered. Shareholders who owned fewer than 100 shares of Lilly common stock, or an “odd lot,” who validly tendered all of their shares were not subject to proration, in accordance with the terms of the Exchange Offer. All shares tendered by eligible odd-lot shareholders have been accepted. The final proration factor of 13.5970839% was applied to all other tendered shares of Lilly common stock to determine the number of such shares that would be accepted. Based on the fi...

threshold = 100...lanco common stock. Because the Exchange Offer was oversubscribed, Lilly accepted only a portion of the shares of Lilly common stock that were validly tendered and not validly withdrawn, on a pro rata basis in proportion to the number of shares tendered. Shareholders who owned fewer than 100 shares of Lilly common stock, or an “odd lot,” who validly tendered all of their shares were not subject to proration, in accordance with the terms of the Exchange Offer. All shares tendered by eligible odd-lot shareholders have been accepted. The final proration factor of 13.5970839% was applied to all other tendered shares of Lilly common sto...

txn_type = TENDER_OFFERSC TO-I/A 1 a18-39904_73sctoia.htm SC TO-I/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE TO (Amendment No. 5) (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 ELI LILLY AND COMPANY (Name of Subject Company (Issuer) and Filing Person (Offeror)) Common Stock, No Par Value (Title of Class of Securities) 532457108 (CUSIP Number of Class of Securities) Michael J. Harrington, Esq. General Counsel Eli Lilly and Compan...

expired_on = 2019-03-08.... Item 4(a) of the Schedule TO, which incorporates by reference the information contained in the Exchange Offer, is hereby amended and supplemented by adding the following thereto: The Exchange Offer expired at 12:00 midnight, New York City time, at the end of the day on March 8, 2019. Lilly accepted for exchange 65,000,775 shares of Lilly common stock in exchange for 293,290,000 shares of Elanco common stock owned by Lilly. Each share of Lilly common stock accepted for exchange by Lilly was exchanged for 4.5121 shares of Elanco common stock. Because the Exch...

proration_pct = 13.5970839...ho validly tendered all of their shares were not subject to proration, in accordance with the terms of the Exchange Offer. All shares tendered by eligible odd-lot shareholders have been accepted. The final proration factor of 13.5970839% was applied to all other tendered shares of Lilly common stock to determine the number of such shares that would be accepted. Based on the final count by the exchange agent, Computershare Trust Company, N.A., the results of the Exchange Offer are as follows: Total number of shar...